Search Results - "Bratslavsky, G."
-
1
Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma
Published in Endocrine-related cancer (01-02-2011)“…Phaeochromocytomas and paragangliomas (PPGLs) are highly heterogeneous tumours with variable catecholamine biochemical phenotypes and diverse hereditary…”
Get full text
Journal Article -
2
HPV-positive clinically advanced squamous cell carcinoma of the urinary bladder (aBSCC): A comprehensive genomic profiling (CGP) study
Published in Urologic oncology (01-12-2023)“…Advanced bladder squamous cell carcinoma (aBSCC) is an uncommon form of urinary bladder malignancy when compared with the much higher urothelial carcinoma…”
Get full text
Journal Article -
3
Comprehensive genomic profiling (CGP) of chemotherapy-resistant, primary mediastinal nonseminomatous germ cell tumors (PMNSGCT)
Published in Annals of oncology (01-10-2018)Get full text
Journal Article -
4
Renal Cell Carcinoma and Prognostic Factors Predictive of Survival
Published in Annals of surgical oncology (01-02-2010)Get full text
Journal Article -
5
Increased prevalence of testicular microlithiasis in men with familial testicular cancer and their relatives
Published in British journal of cancer (18-11-2008)“…Testicular germ cell tumours (TGCT) cluster in families, but responsible genes remain unidentified. The association between testicular microlithiasis (TM) and…”
Get full text
Journal Article -
6
-
7
A stratified genetic risk assessment for testicular cancer
Published in International journal of andrology (01-08-2011)“…Summary Three genome‐wide association studies of testicular cancer have uncovered predisposition alleles in or near KITLG, BAK1, SPRY4, TERT, ATF7IP and DMRT1…”
Get full text
Journal Article -
8
499PIdentification of first-in-class, naturally occurring LAG3 checkpoint inhibitor
Published in Annals of oncology (01-10-2019)“…Abstract Background Despite the impressive impact of CTLA4 and PD-1/L1 cancer immunotherapy, a large proportion of patients with many tumor types fail to…”
Get full text
Journal Article -
9
Identification of first-in-class, naturally occurring LAG3 checkpoint inhibitor
Published in Annals of oncology (01-10-2019)Get full text
Journal Article -
10
499P - Identification of first-in-class, naturally occurring LAG3 checkpoint inhibitor
Published in Annals of oncology (01-10-2019)“…Despite the impressive impact of CTLA4 and PD-1/L1 cancer immunotherapy, a large proportion of patients with many tumor types fail to respond. Lymphocyte…”
Get full text
Journal Article -
11
Hepatic Resection For Metastatic Renal Cell Carcinoma
Published in The Journal of surgical research (2011)Get full text
Journal Article -
12
Urethra is more sensitive to ischemia than bladder: evidence from an in vitro rat study
Published in The Journal of urology (01-06-2001)“…Experimental studies have demonstrated that ischemia may induce significant bladder dysfunction. Because multiple causes leading to bladder ischemia also…”
Get more information
Journal Article -
13
690P Comprehensive genomic profiling (CGP) of VHL mutated and VHL wild type clear cell renal cell carcinoma (ccRCC)
Published in Annals of oncology (01-09-2021)Get full text
Journal Article -
14
-
15
1778P Comparative genomic alterations (GA) landscape in urothelial carcinoma of the bladder (UCB) in patients of South Asian ancestry (SAS)
Published in Annals of oncology (01-09-2022)Get full text
Journal Article -
16
Urachal (U) and Non-Urachal (NU) Adenocarcinomas (adenoCA) of the bladder: A comparative Comprehensive Genomic Profiling (CGP) study
Published in European urology (01-03-2024)Get full text
Journal Article -
17
A0863 - Urachal (U) and Non-Urachal (NU) Adenocarcinomas (adenoCA) of the bladder: A comparative Comprehensive Genomic Profiling (CGP) study
Published in European urology (01-03-2024)Get full text
Journal Article -
18
891P Landscape of NOTCH1 genomic alterations (GA) in head and neck squamous cell carcinoma (HNSCC) and T-ALL
Published in Annals of oncology (01-09-2021)Get full text
Journal Article -
19
2395P Micropapillary histology (MPUC) and extra-cellular domain ERBB2 (ERBB2 ECD+) mutations in urothelial bladder cancer (UBC)
Published in Annals of oncology (01-10-2023)Get full text
Journal Article -
20